- 関
- biochemical marker、biologic marker、biological marker、biomarker、clinical marker、immunologic marker、serum marker、surrogate end point、surrogate endpoint、surrogate marker
WordNet
- make or leave a mark on; "the scouts marked the trail"; "ash marked the believers foreheads"
- formerly the basic unit of money in Germany (同)German mark, Deutsche Mark, Deutschmark
- the impression created by doing something unusual or extraordinary that people notice and remember; "it was in London that he made his mark"; "he left an indelible mark on the American theater"
- a number or letter indicating quality (especially of a students performance); "she made good marks in algebra"; "grade A milk"; "what was your score on your homework?" (同)grade, score
- a visible indication made on a surface; "some previous reader had covered the pages with dozens of marks"; "paw prints were everywhere" (同)print
- a symbol of disgrace or infamy; "And the Lord set a mark upon Cain"--Genesis (同)stigma, brand, stain
- a written or printed symbol (as for punctuation); "his answer was just a punctuation mark"
- designate as if by a mark; "This sign marks the border"
- secure against; "immune from taxation as long as he resided in Bermuda"; "immune from criminal prosecution"
- a person who is immune to a particular infection
- relating to or conferring immunity (to disease or infection) (同)resistant
- (usually followed by `to'
- relating to the condition of immunity; "the immune system"
- a writing implement for making a mark
- some conspicuous object used to distinguish or mark something; "the buoys were markers for the channel"
- a distinguishing symbol; "the owners mark was on all the sheep" (同)marking, mark
PrepTutorEJDIC
- 〈C〉(…の表面についた)『跡』,汚れ,はん点《+『on』+『名』》 / 〈C〉『印』,記号,符号,標章 / 〈C〉《おもに英》(学業などの)『点数』,成績,評価,(…の)得点《+『in』(『for』)+『名』》 / 〈C〉(ある性質の)『徴候』,『特徴』,現れ,様相《+『of』+『名』》 / 〈C〉(思想・生活などに及ぼす)『影響』,感化《+『on』+『名』》 / 〈C〉(境界などの)位置を示すもの,指標,目印 / 〈C〉『的』,標的 / 〈C〉《the mark》水準,標準 / 〈U〉《文》著名,重要性;名声 / 〈C〉(軽べつ・もの笑いなどの)対象,的 / 〈U〉《通例M-》武器記号,…型 / 〈C〉スタートライン / (…で)…‘に'『印をつける』,跡をつける《+『名』++『with』+『名』》 / 〈物が〉…‘を'印となっている,‘を'示している / …‘を'印(記号など)で示す / 〈物・事柄などが〉…‘を'『特徴づける』,目立たせる / 〈答案など〉‘に'点(印)をつける / (…の候補に)…‘を'選び出す《+『名』+『out for』+『名』》 / …‘に'注意を払う,柱目する
- マルク(ドイツノ貨幣単位;《略》『MK.』)
- 免疫の / 《補語にのみ用いて》(影響・攻撃・義務・税などを)免れている《+『against』(『from, to』)+『名』》
- 印をつける人(道具) / (ゲームなどの)採点者 / 目印,目標
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Cardiometabolic biomarkers in chronic plaque psoriasis before and after etanercept treatment.
- Puig L1, Strohal R, Fuiman J, Pedersen R, Szumski A, Koenig AS, Robertson D, Drexel H.
- The Journal of dermatological treatment.J Dermatolog Treat.2014 Dec;25(6):470-81. doi: 10.3109/09546634.2013.848260. Epub 2013 Nov 13.
- OBJECTIVE: To assess cardiometabolic biomarkers in patients with psoriasis before and after etanercept treatment.METHODS: Patients with moderate-to-severe plaque psoriasis were randomized to etanercept 50 mg once or twice weekly, double-blinded. Cardiometabolic biomarkers were assessed at baseline
- PMID 24219012
- Ultrasensitive photoelectrochemical immunoassay of antibody against tumor-associated carbohydrate antigen amplified by functionalized graphene derivates and enzymatic biocatalytic precipitation.
- Zhang X1, Liu M2, Mao Y2, Xu Y2, Niu S3.
- Biosensors & bioelectronics.Biosens Bioelectron.2014 Sep 15;59:21-7. doi: 10.1016/j.bios.2014.02.071. Epub 2014 Mar 18.
- Tumor-associated carbohydrate antigens (TACAs) are often found on the surface of cancer cells. The determination of the carbohydrate components of glycoconjugates is challenging because of the chemical complexity of glycan chains. Through monitoring corresponding antibody, we can get a good solution
- PMID 24690557
- Myogenesis defect due to Toca-1 knockdown can be suppressed by expression of N-WASP.
- George B1, Jain N1, Fen Chong P1, Hou Tan J1, Thanabalu T2.
- Biochimica et biophysica acta.Biochim Biophys Acta.2014 Sep;1843(9):1930-41. doi: 10.1016/j.bbamcr.2014.05.008. Epub 2014 May 24.
- Skeletal muscle formation is a multistep process involving proliferation, differentiation, alignment and fusion of myoblasts to form myotubes which fuse with additional myoblast to form myofibers. Toca-1 (Transducer of Cdc42-dependent actin assembly), is an adaptor protein which activates N-WASP in
- PMID 24861867
Japanese Journal
- Adenosine A2B receptor antagonist PSB603 suppresses tumor growth and metastasis by inhibiting induction of regulatory T cells
- , , ,
- The Journal of Toxicological Sciences 39(2), 191-198, 2014
- … Regulatory T cells (Treg) play a role in suppression of immune response, including anti-tumor immunity. … We have recently reported that treatment of naïve CD4 T cells with adenosine A2B receptor antagonist PSB603 under Treg-skewing conditions inhibits expression of Foxp3, a marker of differentiation to Treg, without blocking IL-2 production or CD25 expression, which are activation markers, in CD4 T cells. …
- NAID 130004903979
- 自家末梢血幹細胞移植後アデノウイルス性出血性膀胱炎を契機にsecondary MGUSを呈した多発性骨髄腫
- 初瀬 真弓,淵田 真一,岡野 晃,村頭 智,島崎 千尋
- 臨床血液 55(11), 2277-2282, 2014
- 症例は61才男性，多発性骨髄腫IgG-κ型と診断され，寛解導入後に自家末梢血幹細胞移植を実施しVGPRを達成した。しかし移植4カ月後，アデノウイルス性出血性膀胱炎とニューモシスチス肺炎にて入院。PSLおよびST合剤にて加療し軽快したが，その後abnormal protein band (APB)の出現を認めた。APBはIgG-λ型，IgM-λ型で腫瘍細胞由来のM蛋白とは異なった。1カ月後IgGは2 …
- NAID 130004705975
- Interleukin-33 Promotes Disease Progression in Patients with Primary Biliary Cirrhosis
- , , , , , , , , , , ,
- The Tohoku Journal of Experimental Medicine 234(4), 255-261, 2014
- … Interleukin-33 (IL-33) is expressed in various non-hematopoietic cells and a certain population of immune cells, and exerts its biological effects by binding to the specific receptor, suppression of tumorigenicity 2 (ST2). … Importantly, the cells that express IL-33 and/or myeloperoxidase (a marker for neutrophils) were accumulated in the livers of PBC patients, and their number increased with the severity of liver lesions. …
- NAID 130004704762
Related Links
- Changes in serum immunity during pregnancy AMERICAN JOURNAL OF HUMAN BIOLOGY, Issue 3 2009 Elizabeth M. Miller Pregnancy requires a host of localized immune factors that allow the mother to tolerate the fetus.
- Statistical analysis To characterize subjects’ immune marker patterns, we classified levels of antibody to EBV nuclear antigen-2 (anti-EBNA2), EBV viral capsid antigen (anti-VCA), CRP, sIL2R, sCD30, neopterin, and total IgE as ...
★リンクテーブル★
[★]
代替エンドポイント、サロゲートエンドポイント
- 関
- biochemical marker、biologic marker、biological marker、biomarker、clinical marker、immune marker、immunologic marker、serum marker、surrogate endpoint、surrogate marker
[★]
- 関
- biologic marker、biological marker、biomarker、clinical marker、immune marker、immunologic marker、serum marker、surrogate end point、surrogate endpoint、surrogate marker
[★]
- 関
- biochemical marker、biologic marker、biological marker、biomarker、clinical marker、immune marker、immunologic marker、serum marker、surrogate end point、surrogate endpoint
[★]
- 英
- immune marker、immunologic marker
- 関
- 生物マーカー、生化学マーカー、代用マーカー、生物学的マーカー、臨床マーカー、血清マーカー、代替エンド・イント、代替マーカー
[★]
- 関
- biochemical marker、biological marker、biomarker、clinical marker、immune marker、immunologic marker、serum marker、surrogate end point、surrogate endpoint、surrogate marker
[★]
- 関
- characterise、characterize、label、labeling、landmark、marker、marking、tag
[★]
- 関
- immunisation、immunise、immunity、immunization、immunize、immuno、immunologic
[★]
- 関
- label、labeling、landmark、mark、marking、tag